Aarti Pharmalabs Limited (NSE:AARTIPHARM)

Aarti Pharmalabs Statistics

Total Valuation

NSE:AARTIPHARM has a market cap or net worth of INR 55.20 billion. The enterprise value is 61.39 billion.

Market Cap	55.20B
Enterprise Value	61.39B

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	Feb 16, 2026

Share Statistics

NSE:AARTIPHARM has 90.66 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	90.66M
Shares Outstanding	90.66M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	29.64%
Owned by Institutions (%)	19.58%
Float	47.90M

Valuation Ratios

The trailing PE ratio is 25.84.

PE Ratio	25.84
Forward PE	n/a
PS Ratio	3.07
PB Ratio	2.70
P/TBV Ratio	2.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	28.72
EV / Sales	3.41
EV / EBITDA	14.99
EV / EBIT	19.10
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.33
Debt / EBITDA	1.66
Debt / FCF	n/a
Interest Coverage	8.71

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.08%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	2.26%
Revenue Per Employee	8.33M
Profits Per Employee	988,657
Employee Count	2,162
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:AARTIPHARM has paid 679.15 million in taxes.

Income Tax	679.15M
Effective Tax Rate	24.11%

Stock Price Statistics

The stock price has decreased by -16.96% in the last 52 weeks. The beta is -0.40, so NSE:AARTIPHARM's price volatility has been lower than the market average.

Beta (5Y)	-0.40
52-Week Price Change	-16.96%
50-Day Moving Average	716.36
200-Day Moving Average	801.71
Relative Strength Index (RSI)	33.46
Average Volume (20 Days)	195,987

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:AARTIPHARM had revenue of INR 18.01 billion and earned 2.14 billion in profits. Earnings per share was 23.56.

Revenue	18.01B
Gross Profit	9.23B
Operating Income	3.19B
Pretax Income	2.82B
Net Income	2.14B
EBITDA	4.02B
EBIT	3.19B
Earnings Per Share (EPS)	23.56

Balance Sheet

The company has 555.56 million in cash and 6.75 billion in debt, with a net cash position of -6.19 billion or -68.30 per share.

Cash & Cash Equivalents	555.56M
Total Debt	6.75B
Net Cash	-6.19B
Net Cash Per Share	-68.30
Equity (Book Value)	20.46B
Book Value Per Share	225.70
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	829.85M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 51.29%, with operating and profit margins of 17.71% and 11.87%.

Gross Margin	51.29%
Operating Margin	17.71%
Pretax Margin	15.64%
Profit Margin	11.87%
EBITDA Margin	22.32%
EBIT Margin	17.71%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.82%.

Dividend Per Share	5.00
Dividend Yield	0.82%
Dividend Growth (YoY)	14.29%
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	0.72%
Earnings Yield	3.87%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2